Who owns CONDUIT PHARMACEUTICALS INC?
- Ticker: CDT
- CUSIP Number: 20678x304
Tip: Access positions for across all investors
Analyze quarterly positions in Conduit Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Conduit Pharmaceuticals stock
Who bought or sold CONDUIT PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Apollon Wealth Management | 108k | $73k | 100% | Sep 2025 |
|
| Citadel Advisors | 36k | $24k | 100% | Sep 2025 |
|
| UBS Group | 16k | $12k | 18% | Sep 2025 |
|
| Tower Research Capital | 1.6k | $1.1k | 60% | Sep 2025 |
|
| Morgan Stanley | 226.00 | $623.692200 | 100% | Jun 2025 |
|
| CWM | 82.00 | $0 | -90% | Sep 2025 |
|
| BlackRock | 74.00 | $50.001800 | 0% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 15.00 | $10.000500 | 0% | Sep 2025 |
|
Who sold out of Conduit Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| FMR | Jun 2025 | 4.5k | $13k |
| Deutsche Bank Aktiengesellschaft | Jun 2025 | 294.00 | $810.999000 |
| SBI Securities | Jun 2025 | 20.00 | $55.000000 |
| EverSource Wealth Advisors | Jun 2025 | 18.00 | $50.000400 |